Emerging Immunotherapy Approaches for Treating Prostate Cancer

被引:11
|
作者
Meng, Lingbin [1 ]
Yang, Yuanquan [1 ]
Mortazavi, Amir [1 ]
Zhang, Jingsong [2 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
关键词
immunotherapy; prostate cancer; immune checkpoint inhibitors; bispecific antibodies; CAR T cells; vaccines; cytokines; immunotherapeutic combinations; CAR-T-CELLS; IMMUNE-CHECKPOINT; DOUBLE-BLIND; PHASE-III; PLUS DOCETAXEL; CLINICAL-TRIAL; SIPULEUCEL-T; TUMOR MICROENVIRONMENT; DNA VACCINE; ANTIGEN;
D O I
10.3390/ijms241814347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunotherapy has emerged as an important approach for cancer treatment, but its clinical efficacy has been limited in prostate cancer compared to other malignancies. This review summarizes key immunotherapy strategies under evaluation for prostate cancer, including immune checkpoint inhibitors, bispecific T cell-engaging antibodies, chimeric antigen receptor (CAR) T cells, therapeutic vaccines, and cytokines. For each modality, the rationale stemming from preclinical studies is discussed along with outcomes from completed clinical trials and strategies to improve clinical efficacy that are being tested in ongoing clinical trials. Imperative endeavors include biomarker discovery for patient selection, deciphering resistance mechanisms, refining cellular therapies such as CAR T cells, and early-stage intervention were reviewed. These ongoing efforts instill optimism that immunotherapy may eventually deliver significant clinical benefits and expand treatment options for patients with advanced prostate cancer.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
    Che, Jizhong
    Liu, Yuanyuan
    Liu, Yangyang
    Song, Jingheng
    Cui, Hongguo
    Feng, Dongdong
    Tian, Aimin
    Zhang, Zhengchao
    Xu, Yankai
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [2] Immunotherapy in Prostate Cancer
    Fay, Emily K.
    Graff, Julie N.
    CANCERS, 2020, 12 (07) : 1 - 17
  • [3] Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma
    Meng, Lingbin
    Collier, Katharine A.
    Wang, Peng
    Li, Zihai
    Monk, Paul
    Mortazavi, Amir
    Hu, Zhiwei
    Spakowicz, Daniel
    Zheng, Linghua
    Yang, Yuanquan
    CELLS, 2024, 13 (01)
  • [4] Is There a Role for Immunotherapy in Prostate Cancer?
    Rizzo, Alessandro
    Mollica, Veronica
    Cimadamore, Alessia
    Santoni, Matteo
    Scarpelli, Marina
    Giunchi, Francesca
    Cheng, Liang
    Lopez-Beltran, Antonio
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Massari, Francesco
    CELLS, 2020, 9 (09) : 1 - 24
  • [5] Beyond Sipuleucel-T: Immune Approaches to Treating Prostate Cancer
    Cheng, Michael L.
    Fong, Lawrence
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (01) : 115 - 126
  • [6] Prostate cancer immunotherapy: the path forward
    Madan, Ravi A.
    Gulley, James L.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2017, 11 (03) : 225 - 230
  • [7] Immunotherapy in castration resistant prostate cancer
    Minana Lopez, Bernardino
    Villacampa Auba, Felipe
    de Fata Chilton, Fernando Ramon
    Ancizu Markert, Francisco Javier
    Garcia Cortes, Angel
    Domenech Lopez, Pablo
    Chiva San Roman, Santiago
    Veils Campillo, Jose Maria
    Diez-Caballero Alonso, Fernando
    Robles Garcia, Jose Enrique
    Roseii Costa, David
    Pascual Piedrola, Juan Ignacio
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (08): : 685 - 695
  • [8] Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?
    von Amsberg, Gunhild
    Alsdorf, Winfried
    Karagiannis, Panagiotis
    Coym, Anja
    Kaune, Moritz
    Werner, Stefan
    Graefen, Markus
    Bokemeyer, Carsten
    Merkens, Lina
    Dyshlovoy, Sergey A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [9] Prostate cancer immunotherapy
    Mitsogiannis, Iraklis
    Tzelves, Lazaros
    Dellis, Athanasios
    Issa, Hussein
    Papatsoris, Athanasios
    Moussa, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 577 - 590
  • [10] Approaches Used in Immunotherapy for Prostate Cancer
    Sonpavde, Guru
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (04) : 238 - 244